Physician profile
David Sellman
NPI 1770074825
$1,551.78
in general payments reported to CMS, 2019-2025
14 companies · $447 in 2025
The $447 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2021: $181 · 2022: $431 · 2023: $162 · 2024: $88.02 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $650.17 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Teleflex LLC | $199.87 | 2025 | Barrigel |
| Axonics, INC. | $159.01 | 2023-2024 | Axonics |
| Medtronic, INC. | $148.65 | 2022 | |
| Urogen Pharma, INC. | $124.89 | 2022 | |
| Tolmar, INC. | $50.19 | 2025 | Jatenzo, Eligard |
| Abbvie INC. | $41.60 | 2025 | |
| Ferring Pharmaceuticals INC. | $39.77 | 2025 | Adstiladrin |
| Telix Pharmaceuticals | $35.85 | 2024 | Illuccix |
| Merck Sharp & Dohme LLC | $31.49 | 2025 | Keytruda |
| Angiodynamics, INC. | $19.62 | 2025 | Nanoknife |
| Endo Pharmaceuticals INC. | $17.89 | 2023 | Xiaflex |
| Coloplast Corp | $16.42 | 2025 | |
| Photocure INC | $16.36 | 2025 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.